Table 4. Laboratory Findings of Patients With COVID-19 With PNS Symptoms.
| Laboratory finding | Median (range) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total | Severe | Nonsevere | ||||||||
| With PNS symptoms (n = 19) | Without PNS symptoms (n = 195) | P value | With PNS symptoms (n = 7) | Without PNS symptoms (n = 81) | P value | With PNS symptoms (n = 12) | Without PNS symptoms (n = 114) | P value | ||
| Count, ×109/L | ||||||||||
| White blood cell | 4.8 (2.8-7.5) | 4.9 (0.1-20.4) | .74 | 4.5 (3.1-6.8) | 5.6 (0.1-20.4) | .11 | 4.9 (2.8-7.5) | 4.4 (1.8-14.0) | .27 | |
| Neutrophil | 2.8 (1.5-5.4) | 3.0 (0.0-18.7) | .74 | 2.6 (1.5-5.3) | 4.1 (0.0-18.7) | .10 | 2.9 (1.9-5.4) | 2.5 (0.7-11.8) | .21 | |
| Lymphocyte | 1.2 (0.6-2.6) | 1.1 (0.1-2.6) | .43 | 1.2 (0.6-1.6) | 0.9 (0.1-2.6) | .26 | 1.2 (0.7-2.6) | 1.3 (0.4-2.4) | .92 | |
| Platelet | 204.0 (111.0-305.0) | 213.0 (18.0-583.0) | .56 | 204.0 (111.0-245.0) | 205.0 (18.0-576.0) | .56 | 214.5 (155.0-305.0) | 219.0 (42.0-583.0) | .81 | |
| C-reactive protein, mg/L | 12.0 (3.1-81.0) | 12.3 (0.1-212.0) | .45 | 7.5 (3.1-76.4) | 43.7 (0.1-212.0) | .13 | 13.0 (3.1-81.0) | 8.8 (0.4-126.0) | .60 | |
| D-dimer, mg/L | 0.4 (0.2-9.5) | 0.5 (0.1-20.0) | .40 | 0.5 (0.2-9.5) | 1.3 (0.1-20.0) | .27 | 0.4 (0.2-4.5) | 0.4 (0.2-8.7) | .99 | |
| Creatine kinase, U/L | 67.0 (32.0-1214.0) | 64.0 (8.8-12216.0) | .41 | 105.0 (32.0-1214.0) | 83.0 (8.8-12216.0) | .76 | 66.0 (42.0-171.0) | 57.5 (19.0-1260.0) | .29 | |
| Lactate dehydrogenase, U/L | 205.0 (2.5-517.0) | 242.0 (2.2-908.0) | .28 | 170.0 (46.0-517.0) | 309.0 (2.2-880.0) | .05 | 254.0 (2.5-481.0) | 215.0 (2.9-908.0) | .67 | |
| Aminotransferase, U/L | ||||||||||
| Alanine | 26.0 (5.0-116.0) | 27.0 (6.0-1933.0) | .70 | 19.0 (5.0-80.0) | 35.0 (8.0-1933.0) | .23 | 26.0 (8.0-116.0) | 23.0 (6.0-261.0) | .56 | |
| Aspartate | 22.0 (8.0-115.0) | 27.0 (9.0-8191.0) | .29 | 22.0 (8.0-53.0) | 35.5 (12.0-8191.0) | .13 | 22.0 (14.0-115.0) | 23.5 (9.0-244.0) | >.99 | |
| Blood urea nitrogen, mmol/L | 4.1 (1.6-8.8) | 4.1 (1.5-48.1) | .76 | 4.2 (3.5-8.8) | 4.7 (1.5-48.1) | .96 | 3.7 (1.6-5.3) | 3.9 (1.7-13.7) | .66 | |
| Creatinine, μmol/L | 62.5 (48.1-121.4) | 68.3 (35.9-9435.0) | .46 | 71.4 (58.3-121.4) | 71.7 (35.9-9435.0) | .72 | 59.9 (48.1-77.3) | 66.6 (39.4-229.1) | .24 | |
Abbreviations: COVID-19, coronavirus disease 2019; PNS, peripheral nervous system.
SI conversion factor: To convert aminotransferase levels to microkatals per liter, multiply by 0.0167; creatine kinase to microkatals per liter, multiply by 0.0167; lactate dehydrogenase to microkatals per liter, multiply by 0.0167.
a
P values indicate differences between patients with and without PNS symptoms, and P less than .05 was considered statistically significant.